Logo image of ABLD.PA

ABL DIAGNOSTICS (ABLD.PA) Stock Fundamental Analysis

EPA:ABLD - Euronext Paris - Matif - FR001400AHX6 - Common Stock - Currency: EUR

5.55  +0.05 (+0.91%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ABLD. ABLD was compared to 16 industry peers in the Trading Companies & Distributors industry. ABLD scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ABLD is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year ABLD was profitable.
In the past year ABLD had a positive cash flow from operations.
In multiple years ABLD reported negative net income over the last 5 years.
ABLD had negative operating cash flow in 4 of the past 5 years.
ABLD.PA Yearly Net Income VS EBIT VS OCF VS FCFABLD.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 1M -1M

1.2 Ratios

ABLD has a Return On Assets of 1.36%. This is comparable to the rest of the industry: ABLD outperforms 43.75% of its industry peers.
ABLD has a Return On Equity of 2.70%. This is comparable to the rest of the industry: ABLD outperforms 43.75% of its industry peers.
Industry RankSector Rank
ROA 1.36%
ROE 2.7%
ROIC N/A
ROA(3y)5.68%
ROA(5y)2.48%
ROE(3y)9.01%
ROE(5y)4.47%
ROIC(3y)N/A
ROIC(5y)N/A
ABLD.PA Yearly ROA, ROE, ROICABLD.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20

1.3 Margins

Looking at the Profit Margin, with a value of 3.13%, ABLD is in the better half of the industry, outperforming 62.50% of the companies in the same industry.
In the last couple of years the Profit Margin of ABLD has declined.
The Operating Margin and Gross Margin are not available for ABLD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 3.13%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y-71%
GM growth 3YN/A
GM growth 5YN/A
ABLD.PA Yearly Profit, Operating, Gross MarginsABLD.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 100 200 300 400

More info and screens

5

2. Health

2.1 Basic Checks

ABLD does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ABLD remains at a similar level compared to 1 year ago.
The number of shares outstanding for ABLD has been increased compared to 5 years ago.
The debt/assets ratio for ABLD is higher compared to a year ago.
ABLD.PA Yearly Shares OutstandingABLD.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M
ABLD.PA Yearly Total Debt VS Total AssetsABLD.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

2.2 Solvency

An Altman-Z score of 8.93 indicates that ABLD is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 8.93, ABLD belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
A Debt/Equity ratio of 0.26 indicates that ABLD is not too dependend on debt financing.
The Debt to Equity ratio of ABLD (0.26) is better than 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z 8.93
ROIC/WACCN/A
WACC7.92%
ABLD.PA Yearly LT Debt VS Equity VS FCFABLD.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 2M 4M 6M

2.3 Liquidity

ABLD has a Current Ratio of 2.06. This indicates that ABLD is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of ABLD (2.06) is better than 62.50% of its industry peers.
A Quick Ratio of 1.92 indicates that ABLD should not have too much problems paying its short term obligations.
With an excellent Quick ratio value of 1.92, ABLD belongs to the best of the industry, outperforming 81.25% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.06
Quick Ratio 1.92
ABLD.PA Yearly Current Assets VS Current LiabilitesABLD.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for ABLD have decreased strongly by -70.74% in the last year.
The earnings per share for ABLD have been decreasing by -66.52% on average. This is quite bad
ABLD shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -47.26%.
The Revenue has been growing by 74.86% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-70.74%
EPS 3YN/A
EPS 5Y-66.52%
EPS Q2Q%675%
Revenue 1Y (TTM)-47.26%
Revenue growth 3YN/A
Revenue growth 5Y74.86%
Sales Q2Q%11.83%

3.2 Future

ABLD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 162.07% yearly.
ABLD is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 32.29% yearly.
EPS Next Y800%
EPS Next 2Y324.26%
EPS Next 3Y162.07%
EPS Next 5YN/A
Revenue Next Year15.22%
Revenue Next 2Y24.43%
Revenue Next 3Y32.29%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ABLD.PA Yearly Revenue VS EstimatesABLD.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2022 2023 2024 2025 2026 2M 4M 6M 8M 10M
ABLD.PA Yearly EPS VS EstimatesABLD.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 0.02 0.04 0.06

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 555.00, which means the current valuation is very expensive for ABLD.
ABLD's Price/Earnings ratio is a bit more expensive when compared to the industry. ABLD is more expensive than 62.50% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.85, ABLD is valued quite expensively.
With a Price/Forward Earnings ratio of 90.69, ABLD can be considered very expensive at the moment.
ABLD's Price/Forward Earnings is on the same level as the industry average.
ABLD is valuated expensively when we compare the Price/Forward Earnings ratio to 20.77, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 555
Fwd PE 90.69
ABLD.PA Price Earnings VS Forward Price EarningsABLD.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300 400 500

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ABLD.PA Per share dataABLD.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3 0.4

4.3 Compensation for Growth

ABLD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ABLD's earnings are expected to grow with 162.07% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.69
PEG (5Y)N/A
EPS Next 2Y324.26%
EPS Next 3Y162.07%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ABLD!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ABL DIAGNOSTICS

EPA:ABLD (4/30/2025, 7:00:00 PM)

5.55

+0.05 (+0.91%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners99.64%
Ins Owner ChangeN/A
Market Cap89.41M
Analysts85.71
Price Target6.28 (13.15%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 555
Fwd PE 90.69
P/S 15.15
P/FCF N/A
P/OCF 112.52
P/B 13.06
P/tB 21.28
EV/EBITDA N/A
EPS(TTM)0.01
EY0.18%
EPS(NY)0.06
Fwd EY1.1%
FCF(TTM)0
FCFYN/A
OCF(TTM)0.05
OCFY0.89%
SpS0.37
BVpS0.43
TBVpS0.26
PEG (NY)0.69
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.36%
ROE 2.7%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 3.13%
GM N/A
FCFM N/A
ROA(3y)5.68%
ROA(5y)2.48%
ROE(3y)9.01%
ROE(5y)4.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y-71%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 13.8%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.06
Quick Ratio 1.92
Altman-Z 8.93
F-Score4
WACC7.92%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-70.74%
EPS 3YN/A
EPS 5Y-66.52%
EPS Q2Q%675%
EPS Next Y800%
EPS Next 2Y324.26%
EPS Next 3Y162.07%
EPS Next 5YN/A
Revenue 1Y (TTM)-47.26%
Revenue growth 3YN/A
Revenue growth 5Y74.86%
Sales Q2Q%11.83%
Revenue Next Year15.22%
Revenue Next 2Y24.43%
Revenue Next 3Y32.29%
Revenue Next 5YN/A
EBIT growth 1Y-76.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year345.32%
EBIT Next 3Y106.69%
EBIT Next 5YN/A
FCF growth 1Y89.17%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y541.44%
OCF growth 3YN/A
OCF growth 5Y62.76%